Europe's only congress dedicated to discussing sequencing and single cell analysis challenges. This year Oxford Global will be focussing on the application of NGS technologies in different therapeutic areas including oncology, microbiology and infectious diseases as well as translating NGS into the clinic. With the discovery of CRISPR, genome editing is poised to revolutionise the genomics industry; join us to hear how CRISPR and other technologies are currently impacting therapeutic research. This is the meeting place for over 400 international experts and co-located with the 3rd Annual Single Cell Analysis Congress and the Genome Editing Congress, this is forecast to be the biggest event of the year.
Who will attend?
The 7th Annual Next Generation Sequencing Congress is an exclusive event consisting of world-class keynote addresses, presentations and panel discussions designed specifically for senior level attendees from research & academic institutions, clinical research institutions, food & nutrition companies as well as major pharmaceutical and biotech companies based mainly in Europe but also worldwide. Delegates typically include Professors, Directors, Managers and Heads of: NGS, DNA Sequencing, RNA Sequencing, Whole Genome Sequencing, Clinical Genetics & Genomics, Cancer Genomics, Cancer Diagnostics, Data Analysis, High Throughput Technologies, Epigenetics, Metagenomics, Genomics, Personalised Medicine, Sequencing Technologies, Bioinformatics and Genome Analysis.
Why this congress?
NGS is one of the fastest growing segments within genomic research. Cheaper and quicker sequencing is triggering ground breaking discoveries in the field, having a striking impact on cancer, rare diseases, immunotherapy and the future development of genomic therapies. Join over 400 delegates and hear over 60 case studies and presentations focused on novel next generation sequencing platforms & technologies, the applications of NGS & key developments in NGS drug development and clinical diagnostics.
Presentations Include:
Genomics England And The 100,000 Genomes Project
Tim Hubbard, Professor of Bioinformatics, King's College London, Head of Bioinformatics, Genomics England, Honorary Faculty, Wellcome Trust Sanger Institute
Application Of Next Generation Sequencing To The Study Of The Molecular Pathogenesis Of The Myelodysplastic Syndromes
Jacqueline Boultwood, Professor in Molecular Haematology, John Radcliffe Hospital, University of Oxford
Clinical Applications Of NGS: How Far Have We Got?
Peter J. Wild, Professor, Systems Pathology & Clinical HT Genomics Lab, Institute of Surgical Pathology, Univ. Hospital Zurich
Application Of Single Molecule Sequencing Techniques On Genomic Characterisation And Geno-epidemiology Of Cryptosporidium Clinical Isolates
Justin Pachebat, Senior Lecturer Microbial Genomics, Aberystwyth University
Application Of NGS For The Discovery Of Novel Antimicrobials
Mathew Upton, Reader in Medical Microbiology, Plymouth University
To download the agenda, which includes all speakers currently confirmed for the congress, please click here.
Registration is Open.
Please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk or call on +44(0)1865 248455 today to reserve your place.
If you're looking to present a poster, we have limited spaces available on a strictly first come first served basis. For further information regarding our poster presentations, or to find out more about this or any of our upcoming events, please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk or +44(0)1865 248455